Live attenuated oral vaccine against ETEC and typhoid fever
AssigneeProtein Potential, LLC
InventorsYun Wu, Dennis J. Kopecko, B. Kim Lee Sim, Stephen L. Hoffman
Life of this patent
Estimating the term…
Loading patent…
AssigneeProtein Potential, LLC
InventorsYun Wu, Dennis J. Kopecko, B. Kim Lee Sim, Stephen L. Hoffman
Estimating the term…
Disclosed is the attenuated Salmonella typhi vaccine Ty21a utilized as a vector for Shigella and/or enterotoxogenic E. coli genes stably integrated in the Ty21a chromosome. These genes include a heterologous Shigella sonnei O-antigen biosynthetic gene region that comprises the wzz gene and expresses Shigella sonnei form 1 O-antigen, as well as a heterologous acid resistance biosynthetic gene system comprising a YbaS gene, which enables increased stability of the Ty21a vector at pH 2.5 relative to Ty21a without the integrated acid resistance biosynthetic gene system.
A transgenic Salmonella typhi Ty21a comprising a heterologous enterotoxogenic Escherichia coli (ETEC) antigen biosynthetic gene region and a heterologous acid resistance biosynthetic gene system comprising one or more heterologous Shigella acid resistance enzymes, wherein:
Dependencies are inferred from the claim text.